Evidence map›Paper›PMID 40965925›Full record

Trial reportExperimental and clinical psychopharmacology2025

Effects of very low nicotine content cigarettes and concurrent provision of e-cigarettes on symptoms of depression and anxiety.

Katya A Nolder, Diann E Gaalema, Brian R Katz, Jennifer W Tidey, Stacey C Sigmon, Sarah H Heil, Dustin C Lee, Michael DeSarno, Elias M Klemperer, Katherine E Menson and 4 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Experimental and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katya A NolderDepartment of Psychiatry, University of Vermont.ORCID 0009-0008-5648-6851
Diann E GaalemaDivision of Cardiovascular Medicine, University of Texas Medical Branch.
Brian R KatzDivision of Cardiovascular Medicine, University of Texas Medical Branch.
Jennifer W TideyCenter for Alcohol and Addiction Studies, Brown University.
Stacey C SigmonDepartment of Psychiatry, University of Vermont.
Sarah H HeilDepartment of Psychiatry, University of Vermont.
Dustin C LeeBehavioral Pharmacology Research Unit, Johns Hopkins University.
Michael DeSarnoTobacco Center of Regulatory Science, University of Vermont.
Elias M KlempererDepartment of Psychiatry, University of Vermont.
Katherine E MensonTobacco Center of Regulatory Science, University of Vermont.
Patricia A CioeCenter for Alcohol and Addiction Studies, Brown University.
Shirley PlucinskiDepartment of Psychiatry, University of Vermont.
Rhiannon C WileyDepartment of Psychiatry, University of Vermont.
Stephen T HigginsDepartment of Psychiatry, University of Vermont.

Funding

VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HATSUKAMI, DOROTHY K · 2011 to 2022
$64.7M
Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI KHADANGA, SHERRIE · 2013 to 2022
$21.3M
University of Vermont Tobacco Center of Regulatory ScienceU54DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2018 to 2022
$19.4M
TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
Vermont Center on Behavior and HealthP30GM149331 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Stephen T Higgins · 2023 to 2026
$5.6M
National Institute on Drug Abuse/Food and Drug Administration/National Institutes of HealthNIDA NIH HHS T32 DA007242NIDA NIH HHS U54 DA031659NIDA NIH HHS U54 DA036114NIGMS NIH HHS P20 GM103644NIGMS NIH HHS P30 GM149331NIH HHS
6 · The paper itself

Abstract

A national nicotine-reduction policy could reduce cigarette smoking in the United States. The present study evaluated effects of cigarettes varying in nicotine content and provision of e-cigarettes on affective symptoms in populations with vulnerabilities to smoking. The overarching aim was to examine whether a nicotine-reduction policy could have unintended negative consequences, including exacerbation of psychiatric symptoms. This is a secondary analysis of three parallel 16-week randomized clinical trials examining four experimental conditions: normal nicotine content cigarettes, very-low-nicotine-content (VLNC) cigarettes, VLNC cigarettes plus e-cigarettes restricted to tobacco flavor (VLNC + TF), or VLNC cigarettes plus e-cigarettes in preferred flavors (VLNC + PF). Participants were adults who smoked daily from three vulnerable populations: socioeconomically disadvantaged reproductive-aged women (

Indexed as

AnxietyDepressionElectronic Nicotine Delivery SystemsNicotineTobacco ProductsAdultFemaleHumansMaleMiddle AgedYoung AdultNicotine

Identifiers

PMID40965925
PMCPMC12584977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.